Followers | 10 |
Posts | 1578 |
Boards Moderated | 0 |
Alias Born | 10/15/2014 |
Friday, October 27, 2017 4:40:41 PM
"Therapeutic substitution of L-T3 for L-T4 has been evaluated in hypothyroid subjects in a blinded crossover study with a multiple daily dosing scheme, and comparison of L-T3 and L-T4 doses that produce equivalent steady-state thyroidstimulating hormone (TSH) levels additionally resulted in L-T3-mediated weight loss and positive changes to lipid profiles without appreciable side-effects (1,2). A sustained-release L-T3 formulation could avoid issues of noncompliance to multiple daily dosing regimens."
So, T3 has already been studied as a substitute for T4 in a separate study (not run by Titan), and resulted in weight loss and positive changes to cholesterol levels.
"In beagle dogs, which closely match implant-derived serum levels seen in humans, the initial peak release from 3 implants (Cmax = 221 ng/dL,Tmax = 6 hours) was about 1.7-times that of the Css (128 ng/dL), which was sustained from 12 hours post-implantation through Month 8. Residual content analysis of implants removed on post-implantation Day 217 indicated that an average of 21% of the original L-T3 content was released. Assuming similar release characteristics in humans, 1 implant (227 mg L-T3/implant, 3 x 26 mm) will release the equivalent of ~25 mcg oral L-T3/day for >3 years following a single treatment."
Am I reading this right? A THREE YEAR implant???
"Serum samples taken before and after implant removal from dogs on Day 217 were also assayed for LDL, HDL and triglycerides levels. LDL levels went up from 4 mg/dL to 7 mg/dL, peaking at 48 hours post-implant removal. Triglycerides levels also rose from 31 mg/dL to 54 mg/dL, peaking at 12 hours post-implant removal (inset), and HDL levels dropped from 131 mg/dL to 118 mg/dL, with a trough at 24 hours post-removal (inset)."
So following removal of the Titan's implant, HDL (the “good cholesterol” decreased) and LDL and triglycerides (the “bad cholesterol”) increased, consistent with the findings in other studies.
Recent TTNP News
- Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] • Edgar (US Regulatory) • 08/21/2024 12:32:38 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 08/19/2024 08:23:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/19/2024 08:22:56 PM
- Titan Pharmaceuticals Enters Into Merger Agreement With KE Sdn. Bhd. • GlobeNewswire Inc. • 08/19/2024 08:11:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/15/2024 01:29:55 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/15/2024 01:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/25/2024 09:33:11 PM
- Titan Pharmaceuticals Fully Compliant With NASDAQ Listing Criteria • GlobeNewswire Inc. • 01/25/2024 09:29:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/18/2024 09:59:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 10:13:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 09:30:20 PM
- Titan Pharmaceuticals Announces Reverse Stock Split and Ratio • GlobeNewswire Inc. • 12/28/2023 09:15:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2023 09:47:46 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/17/2023 09:03:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/15/2023 09:05:15 PM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM